Safety and Efficacy of Pazopanib Prior to Planned Nephrectomy in Metastatic ccRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
JAMA Oncol 2016 Oct 01;2(10)1303-1309, T Powles, N Sarwar, A Stockdale, SJ Sarker, E Boleti, A Protheroe, R Jones, S Chowdhury, J Peters, G Oades, T O'Brien, M Sullivan, M Aitchison, L Beltran, D Worth, K Smith, C Michel, G Trevisan, E Harvey-Jones, A Wimalasingham, A Sahdev, C Ackerman, S CrabbFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.